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ICU mortalityAbstract Objectives: Evaluation of fluid responsiveness of septic shock patients admitted to sur-
gical ICU and the predictability of non-invasive monitoring and estimated lactate/pyruvate (L/P)
ratio for survival of these patients.
Patients and methods: The study included 58 septic shocked patients admitted and managed at sur-
gical ICU. After non-invasive determination of baseline hemodynamic data and calculation of
shock index (SI-0) and Pleth variability index (PVI-0), all patients received intravenous colloid infu-
sion followed 15-min later by non-invasive re-evaluation for SI-15 and PVI-15. Blood samples were
obtained for estimation of blood lactate and pyruvate levels at admission (BLL-0 and BPL-0) and
12-h after fluid resuscitation (BLL-12 and BPL-12) and L/P ratio was calculated. All patients were
managed according to the Surviving Sepsis Campaign guidelines and followed up for ICU mortality
rate (MR).
Results: ICU stay MR was 20.7%. Survival showed negative significant correlation with PVI, L/P
ratio and BLL, while it showed positive significant correlation with BPL. Receiver Operating Char-
acteristic (ROC) curve analysis defined baseline and persistently low PVI, high BLL and L/P ratio
as significant sensitive predictors for MR, while elevated BPL-12 as significant specific predictor for
survival. Regression analysis defined persistently elevated L/P ratio as the highly significant specific
predictor, while persistently disturbed SI and PVI could predict mortality as screening tests. Odds
ratio for mortality at BLL-0 of >2 mmol/L was 0.0321 (95% CI: 0.0037–0.2755), while it was
4.1111 (95% CI: 1.0702–15.792) at BLL-0 >4 mmol/L.
Conclusion: After fluid resuscitation and hemodynamic stability, persistently elevated BLL could
predict mortality, while elevated BPL could predict survival of septic shock patients. Continuous
non-invasive evaluation of fluid responsiveness judged by PVI and SI could provide sensitive2.
452 A.A. Mohamed, A. Essamscreening for survival outcome of shocked patients. Wider scale comparative studies are mandatory
for establishment of discriminative PVI and BLL cutoff points for prediction of survival of shocked
patients.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Shock is a life-threatening syndrome of acute circulatory fail-
ure. It can be caused by loss of intravascular volume, obstruc-
tion of flow through the vascular compartment, or a
generalized state of vasodilation [1]. Shock leads to decreased
organ perfusion, with inadequate delivery of oxygenated blood
to tissues and resultant end-organ dysfunction [2].
Sepsis is a systemic response to infection, which may pro-
gress to severe sepsis and septic shock [3]. Septic shock causes
vascular dysregulation making tissue perfusion dependent on
blood pressure. Furthermore, microvascular perfusion could
be disrupted by circulating inflammatory mediators that
directly damage the peripheral vascular bed [4]. Microcircula-
tory dysfunction has been documented in the early phase of
sepsis and its severity has been related to poor outcome [5].
In critically ill septic patients, early hemodynamic resuscita-
tion was effective to restore macro-hemodynamia and myocar-
dial contractility. Fluid responsiveness is defined by a cardiac
preload challenge by fluid infusion resulting in augmented
stroke volume and cardiac output [6]. Currently, both static
and dynamic parameters are utilized for prediction of fluid
responsiveness [7].
Static parameters as central venous pressure and pul-
monary artery occlusion pressure are much less reliable than
dynamic parameters, which are based on respirophasic varia-
tion in stroke volume as pulse pressure variation and changes
in aortic blood flow. However, most common dynamic param-
eters are invasive and expensive [8]. Klijn et al. [9] demon-
strated that in critically ill septic patients, non-invasively
assessed tissue perfusion and oxygenation is not inferior to
invasive hemodynamic measurements in monitoring fluid
responsiveness.
Mitochondrial function is thought to play a role in sepsis-
induced multiple organ failure [10]. In septic patients, inflam-
matory signaling leads to changes in the phosphorylation state
of mitochondrial proteins resulting in a reduction of the mito-
chondrial membrane potential, and consequently a lack of
energy, which can cause organ failure and death [11]. Septic
shock induced a severe hypotension in association with meta-
bolic acidosis and significantly decreased rates of mitochon-
drial oxygen consumption, activity and content of
cytochrome c oxidase [12].
The blood lactate-to-pyruvate (L/P) molar ratio reflects the
equilibrium between product and substrate of the reaction cat-
alyzed by lactate dehydrogenase that favors lactate production
and normally maintains a constant L/P ratio of about 10:1
[13]. The L/P ratio is correlated with the cytoplasmic ratio
between the reduced and oxidized forms of nicotinamide ade-
nine dinucleotide (NADH:NAD+) and is used as a surrogate
measure of the cytosolic oxido-reduction state. Impaired cellu-
lar respiration, as in hypoxia, causes reduced pyruvate oxida-
tion, resulting in lactic acidosis and increased L/P ratio [14].Romijn et al. [15] using isotopic tracer found pyruvate and lac-
tate tracer-to-tracer ratios equilibrated almost completely
within 3–4 min in whole blood, thus indicating a very rapid
lactate clearance.
The current study aimed to evaluate fluid responsiveness of
septic shock patients admitted to surgical ICU and the pre-
dictability of non-invasive monitoring and estimated lactate/
pyruvate (L/P) ratio for survival of these patients.
2. Patients and methods
The current prospective multi-center study was conducted at
surgical ICU centers at Cairo University Hospitals, Naser
Institute, Al-Marwa and Demascus private centers since Jan-
uary 2014 till June 2015. The study protocol was approved
by the Local Ethical Committee of Cairo University Hospitals
and written fully informed consents were signed by near
patients’ relatives.
Patients inclusion relied on shock definition as hypoperfu-
sion of tissues and/or organs manifested as systolic blood pres-
sure (SBP) of 690 mmHg, heart rate (HR) increased byP10%
from baseline, urine output (UOP) of <0.5 ml/kg/min for
>2 h, presence of skin mottling; and/or blood lactate level
of >2 mmol/L [16]. Sepsis was diagnosed depending on the
presence of at least two of the four systemic inflammatory
response syndrome (SIRS) criteria and fulfilled the require-
ments for either severe sepsis or septic shock. SIRS criteria
include body temperature <36 C or >38 C, heart rate
(HR) > 90 beats/min, respiratory rate >20 breaths/min or,
an arterial partial pressure of CO2 <32 mmHg and/or white
blood cell count <4000 cells/mm3 or >12,000 cells/mm3, or
the presence of greater than 10% immature neutrophil band
forms. Requirements for severe sepsis patients included the fol-
lowing: (i) fulfilling at least 2 or more of SIRS criteria, (ii) an
associated or suspected source of infection, and (iii) it has one
or more of the following: evidence of end organ damage,
serum lactate levels ofP4 mg/dL, and episode of hypotension
(<90/60 mmHg), which responds to initial fluid resuscitation.
Septic shock patients must have the diagnostic criteria for sev-
ere sepsis but blood pressure was persistently <90/60 mmHg
and did not respond to adequate fluid resuscitation [17].
Clinical evaluations entail collection of demographic data
including age, gender, and body mass index data. Body injury
severity was assessed using scoring on the anatomical abbrevi-
ated injury scale and the scores of the three most severely
injured body regions were squared and added together to pro-
duce the injury severity scale (ISS) score ranking from 0 to 75
indicating unsurvivable injury [18]. Acute physiology and
chronic health evaluation II (APACHE II) [19] and Glasgow
Coma Scale (GCS) [20] scores were also determined.
Patients were continuously non-invasively monitored for
electrocardiogram, blood pressures (SBP, DBP and MAP),
HR and temperature. Severity of hemodynamic compromise
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blood pressure divided by heart rate, with a normal range of
0.5–0.7 in healthy adults [21].
A reusable Rad7 sensor was attached to the index or middle
fingertip, and the sensor was covered with a black, opaque pro-
tector to reduce the interference by the surrounding lights, as
recommended by the manufacturer. Then the sensor was con-
nected to the Masimo Radical 7 device equipped with a soft-
ware ver. 7.8.0.1 (Masimo Corp., Irvine, CA, USA). Rad7
device continuously non-invasively measures total hemoglobin
(SpHb) and perfusion index (PI) which is the ratio of nonpul-
satile to pulsatile blood flow through the peripheral capillary
bed as it can influence SpHb measurement accuracy [22]. Pleth
variability index (PVI) is an automatic measure of the dynamic
change in PI that occurs during the respiratory cycle. PVI =
(PI maximum–PI minimum) divided by PI maximum; thus,
PVI is a representative measure for PI change and helps to pre-
dict fluid responsiveness [23].
Venous blood samples were obtained by venipuncture
under complete aseptic conditions and without use of tourni-
quet. One sample was taken anaerobically in 3-ml heparinized
syringes and analyzed on a bedside blood gas machine.
Another blood samples were taken and divided into three
parts:
1. The first part was collected in sodium fluoride tubes for esti-
mation of blood lactate level using Beckman Coulter ana-
lyzers by an end-point enzymatic reaction [24].
2. One ml of blood was put in tube containing 2.5 ml of 6%
perchloric acid prechilled prior to draw for measurement
of blood pyruvate level manually by an end-point enzy-
matic assay with lactate dehydrogenase and oxidation of
NADH to NAD+ with spectrophotometry [25]. Then, lac-
tate/pyruvate (L/P) ratio was calculated.
3. The third part was put in EDTA tube (about 1.8 mg trik
EDTA/1 ml blood) for at once hemoglobin estimation
and complete blood count.
3. Management
For all patients after obtaining preliminary baseline measure-
ments, intravenous volume expansion was conducted with
rapid infusion, over 10 min, of 500 ml of available colloid solu-
tion and then all hemodynamic measurements were re-
evaluated 5-minutes after the end of infusion, to determine
the response for volume expansion [26]; then, patients were
managed according to the response.
Patients were managed according to the Surviving Sepsis
Campaign guidelines [27]. Briefly, fluid resuscitation was con-
ducted using crystalloid given at a minimum rate of 30 ml/kg
[26] according to dynamic indices of preload as judged by PI
and PVI. Norepinephrine (NE) was used as the first line vaso-
pressor in a dose of 0.05–0.24 lg/kg/min in order to achieve a
MAP of 65 mmHg or achieve increased SBP by P20 mmHg
[28]. Positive inotropes using dobutamine infusion, starting
with an initial dosage of 5 microg  kg  min, increased to a
maximum of 10 lg/kg/min [29] for patients with low cardiac
index. Vasopressin (up to 0.03 U/min) can be added to nore-
pinephrine with the intent of raising MAP to target or decreas-
ing norepinephrine dosage [26]. Hydrocortisone was startedwith a loading dose of 100 mg given within 30 min and fol-
lowed by a continuous infusion of 0.18 mg/kg/h. When septic
shock had been reversed, the dose of hydrocortisone was
reduced to 0.08 mg/kg/h. This dose was kept constant for
6 days. As soon as the underlying infection had been treated
successfully or sodium serum concentrations had increased to
>155 mmol/L, the hydrocortisone infusion was tapered in
steps of 24 mg/day [30]. Renal replacement therapy was used
only in patients exhibiting anuria or elevated potassium levels.
The ambient temperature of the room was consistent at
approximately 23–25 C (climate controlled).
4. Statistical analysis
Considering sepsis, severe sepsis and septic shock is not so fre-
quent surgical complication and to properly evaluate the pre-
dictors for survival as primary outcome, sample size was
calculated using the standard nomogram proposed by Krae-
mer and Theimann [31] and a sample size of 50 patients was
determined to be sufficient to detect a difference at the 5% sig-
nificance level and give the trial 80% power [32]. Sample size
and power were re-calculated and assured using Power and
Sample Size Calculation Software program provided by
Department of Biostatistics, Vanderbilt University.
Obtained data were presented as mean with standard devi-
ation, median with IQR at 25% and 75% levels, numbers and
percentages. Results were analyzed using Wilcoxon ranked test
for unrelated data (Z-test) and Chi-square test (X2 test) for
non-parametric analysis of numbers and ratios. Estimated
parameters were evaluated as predictors from mortality using
the receiver operating characteristic (ROC) curve analysis
judged by the area under the curve (AUC) compared versus
the null hypothesis that AUC= 0.05. Regression analysis
(Stepwise method) was used for stratification of studied
parameters as specific predictors. Statistical analysis was con-
ducted using the SPSS (Version 15, 2006; SPSS Inc., Chicago,
IL, USA) for Windows statistical package. P value <0.05 was
considered statistically significant.
5. Results
The study included 58 septic shocked patients admitted to sur-
gical ICU; demographic and preliminary clinical examination
data are shown in Table 1. Throughout ICU stay 12 patients
died, while 46 patients were discharged alive for a mortality
rate of 20.7%.
Mean SI estimated after trial fluid infusion (SI-15) was sig-
nificantly (p< 0.05) lower compared to at admission SI (SI-0).
Mean estimated SI-0 and SI-15 showed non-significant
(p> 0.05) difference between survivors and non-survivors
(Fig. 1). However, the frequency of survivors among those
who had IS-0 in range of 0.5–0.7 was significantly higher after
fluid resuscitation than those at admission frequency and in
comparison with frequency among non-survivors after resusci-
tation. Mean PVI-15 was significantly (p< 0.05) higher com-
pared to PVI-0 in both survivors and non-survivors. However,
mean PVI-0 and PVI-15 estimates were significantly higher in
survivors compared to non-survivors. Moreover, the percent-
age of change of PVI-15 versus PVI-0 was significantly
(p< 0.05) higher in survivors compared to non-survivors
(Table 2, Fig. 2).
Table 1 Patients’ data at admission (n= 58).
Data Findings
Demographic data Age (years) 42.8 ± 11.6
Male: Female ratio 2.22:1
BMI (kg/m2) 29.3 ± 2.5
Cause of shock Abdominal 15 (25.9%)
Chest 5 (8.6%)
Soft tissue infections 7 (12.1%)
Post-traumatic 13 (22.4%)
Postoperative 18 (31%)
General examination Temperature (C) 38 ± 0.7
Pulse rate (beat/min) 79 ± 23
Arterial blood pressure data (mmHg) Systolic 89 ± 8
Diastolic 59 ± 7
Mean 69 ± 6
Injury severity scoring APACHE II 23.8 (18–34)
GCS 11.8 (6–15)
ISS 27.5 (9–57)
pH 7.3 ± 0.14
Hemoglobin conc. (%) 7.8 ± 1.3
Urinary output (ml/kg/min) 0.44 ± 0.62
Data are presented as numbers and mean ± SD; percentages and ranges are in parenthesis; APACHE II: acute physiology and chronic health
evaluation II; GCS: Glasgow Coma Scale scores; ISS: injury severity scale.
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Figure 1 Mean SI (Shock Index) determined at time of admission and after fluid infusion in studied patients categorized according to
survival.
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judged by SI and PVI, all patients received fluid therapy with
median amount of 1700 cc received initially and 2500 cc 8 h
thereafter. Empirical antibiotic therapy was started once
patient was admitted and after obtaining samples: blood and
fluid, or exudates if possible for culture and sensitivity test to
define the appropriate antibiotic to be given. Forty-two
patients (72.4%) received norepinephrine at time of admission
and 27 (46.6%) patients required booster dose of nore-
pinephrine 8-h thereafter. Thirteen patients (22.4%) received
dobutamine at time of admission and 7 patients (12.1%)required a booster dose at 8-h thereafter. Steroid and vaso-
pressin therapy was required for 32 (55.2%) and 14 patients
(24.1%), respectively. Details of received therapeutic lines are
shown in Table 3.
Median hemoglobin concentration was 7.8 g% at ICU
admission, so all patients received fresh blood transfusion with
median number of transfused units of two units. All patients
showed increased post-transfusion hemoglobin concentration
with significant (p< 0.05) difference versus at admission con-
centration, but with non-significant (p> 0.05) difference
between survivors and non-survivors (Fig. 3). Mean UOP
Table 2 SI and PVI data reported at ICU admission and after trial of fluid infusion of studied patients (n= 58) categorized according
to survival.
Parameter Survivors (n= 46) Non-survivors (n= 12)
SI At ICU admission (SI-0) 0.89 ± 0.25 1.05 ± 0.35
After fluid infusion (SI-15) 0.74 ± 0.14 0.88 ± 0.25
Frequency of patients according to SI determined
at ICU admission and 2-h later
<0.5 0/2 0
0.5–0.7 11/17 2/3
>0.7–1 23/26 5/5
P1 12/1 5/4
PVI At ICU admission (PVI-0) 18 ± 3 13.8 ± 4*
After fluid infusion (PVI-15) 23.1 ± 3.2 17 ± 3.3y,
D PVI 5.1 ± 1.3 3.2 ± 1.1
SI: shock index = SBP/HR; SI-0: shock index determined at ICU admission; SI-15: shock index determined at 15 min after fluid infusion; PVI:
pleth variability index = perfusion index (maximum-minimum)/PI maximum; PVI-0: pleth variability index determined at ICU admission; PVI-
15: pleth variability index determined at 15 min after fluid infusion.
* p< 0.05.
y p< 0.01: significant difference between survivors and non-survivors.
 <0.001: significant difference versus at ICU admission.
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Figure 2 Mean PVI estimated at time of admission and after fluid infusion in studied patients categorized according to survival
( significant versus non-survivors; significant versus at admission).
Disturbed fluid responsiveness and lactate/pyruvate ratio 455was significantly (p< 0.05) increased after fluid resuscitation
compared to at admission UOP in both survivors and non-
survivors. However, mean UOP after fluid resuscitation was
significantly (p< 0.05) higher in survivors than in non-
survivors (Fig. 4).
Blood lactate levels estimated at time of admission (BLL-0)
were significantly (p< 0.05) higher in non-survivors compared
to BLL-0 of survivors. On contrary, blood pyruvate levels
(BPL-0) were non-significantly (p> 0.05) lower in non-
survivors compared to survivors. Fluid resuscitation signifi-
cantly (p< 0.05) reduced BLL estimated at 12-h after admis-
sion (BLL-12) in both survivors and non-survivors compared
to at admission levels. However, BLL-12 was significantly
(p< 0.05) lower, while BPL-12 was significantly (p< 0.05)
higher in survivors compared to non-survivors. Estimated L/
P ratio after fluid resuscitation (L/P-12) was significantly lowerin both survivors and non-survivors compared to at admission
ratios (L/P-0). Estimated L/P ratios were significantly
(p< 0.05) higher in non-survivors compared to survivors
(Table 4, Fig. 5). Eleven non-survivors and 34 survivors
(73.9%) had BLL-0 >2 mmol/L, with Odds ratio (OR) for
survival of 0.0321 (95% CI: 0.0037–0.2755). On contrary, 6
non-survivors (50%) and only 9 survivors (19.6%) had BLL-
0 >4 mmol/L, with OR of 4.1111 for mortality (95% CI:
1.0702–15.792) (Fig. 6).
Survival of shocked patients showed negative significant
correlation with PVI-0, L/P-0 ratio and BLL-0 in decreasing
order of significance, while it showed positive significant corre-
lation with BPL-0. After fluid resuscitation, patients’ survival
showed negative significant correlation with L/P-12 ratio,
PVI-15, BLL-12 and SI-15 in decreasing order of significance,
while it showed positive significant correlation with BPL-12
456 A.A. Mohamed, A. Essamand UOP-12 in decreasing order of significance (Table 5).
BLL-12 estimated 12-h after fluid resuscitation showed nega-
tive significant correlation with UOP-12 (r= 0.436,
p= 0.001).
Among studied parameters evaluated at time of ICU
admission, Receiver Operating characteristic (ROC) curve
analysis defined low PVI-0, but high BLL-0 and L/P-0 ratio
as sensitive significant predictors for mortality during ICU
stay. After fluid resuscitation, ROC curve analysis defined per-
sistently elevated BLL-12 and L/P-12 ratio, while low PVI-15
as sensitive significant predictors for mortality. On contrary,
elevated BPL-12 after fluid resuscitation was defined as signif-
icant specific predictor for survival during ICU stay (Table 6).
Among studied parameters Regression analysis defined per-
sistently elevated L/P ratio after fluid resuscitation and estab-
lishment of stable hemodynamic variables as the highly
significant specific predictor for ICU mortality of septic
shocked patients. Persistently disturbed PVI indicating unfa-
vorable fluid responsiveness could predict mortality as screen-
ing test that was positive in two analysis models. Also,
persistently high SI despite fluid resuscitation was significant
screening test for mortality during ICU stay (Table 7).Table 3 Therapeutic lines received by studied patients at time of c
T
Fluid therapy T
T
Vasoactive agent Norepinephrine (lg/kg/min) T
T
Dobutamine (lg/kg/min) T
T
Steroid (mg/kg/h)
Vasopressin (U/min)
Data are presented as numbers and percentages for frequency; Median
± SD for drugs.
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Figure 3 Mean hemoglobin concentrations estimated at time of a
according to survival.6. Discussion
Fluid resuscitation significantly improved shock index (SI) and
the frequency of survivors with SI in range of 0.5–0.7 after
fluid resuscitation was significantly higher compared to non-
survivors and persistently elevated SI predicts mortality with
AUC of 0.670. In line with these findings, Berger et al. [33]
reported that SIP 0.7 could predict the presence of severe sep-
sis and was the most sensitive screening test, while SIP 1.0
was the most specific predictor for 28-day mortality. Wira
et al. [34] found that 47.5% of patients with severe sepsis
had sustained SI elevation after fluid resuscitation and
38.6% of these patients required vasopressors within 72 h ver-
sus 11.6% of patients without sustained SI elevation and the
mean number of organ failures was 4 and 3.2 in patients with
and without sustained SI elevation, respectively. McCall et al.
[35] reported that SI at extremely high and low values could
predict stroke mortality and very early (3-day) mortality.
All patients showed significantly improved PVI after fluid
therapy compared to PVI-0 with significant difference in favor
of survivors. PVI measurements showed positive significant
correlation with survival and were defined as significantatheter insertion and 8-h later.
ime Number (%) Dose
0 58 (100%) 1700 (IQR: 1500-2300)
8 58 (100%) 2500 (IQR: 2400-2700)
0 42 (72.4%) 0.17 ± 0.04 (0.1–0.24)
8 27 (46.6%) 0.19 ± 0.04 (0.12–0.26)
0 13 (22.4%) 7.7 ± 1.8 (5–11)
8 7 (12.1%) 7.4 ± 2.2 (4–10)
32 (55.2%) 14 ± 2.6 (8–19)
14 (24.1%) 0.047 ± 0.015 (0.03–0.08)
and interquartile ratio (IQR 25–75%) for fluids received and mean
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Figure 4 Mean urine output (UOP) determined at time of admission and after fluid infusion in studied patients categorized according to
survival.
Table 4 Laboratory data reported at ICU admission and after fluid resuscitation of studied patients categorized according to survival.
Parameter Survivors (n= 46) Non-survivors (n= 12)
Hg conc. (g%) At ICU admission 8 ± 1.3 7.1 ± 1.2
After fluid resuscitation 9 ± 1.1 8.4 ± 1.1
Number of transfused blood units 1.6 ± 0.7 2 ± 0.7
UOP (ml/kg/min) At ICU admission 0.5 ± 0.14 0.52 ± 0.16
After fluid resuscitation 0.73 ± 0.11 0.65 ± 0.13*
L/P data At ICU admission Blood lactate 2.9 ± 1 3.94 ± 1.6*
Blood pyruvate 0.2 ± 0.05 0.16 ± 0.06
L/P 15.6 ± 7.7 26.2 ± 8.7y
12-h after admission Blood lactate 1.89 ± 0.52 3.4 ± 1.15y
Blood pyruvate 0.28 ± 0.05 0.23 ± 0.08*
L/P 6.95 ± 2.4 15.3 ± 3.1y
Hg%: hemoglobin concentration; UOP: urine output; L/P: lactate/pyruvate ratio.
* p< 0.05.
y p< 0.01: significant difference between survivors and non-survivors.
Disturbed fluid responsiveness and lactate/pyruvate ratio 457predictors for survival on ROC curve analysis. These findings
indicate the applicability of PVI as sensitive parameter for
non-invasive continuous monitoring of fluid responsiveness,
despite being less specific and go in hand with Loupec et al.
[23] who found PVI changes significantly correlated with the
percentage change in cardiac output after fluid challenge and
PVI at 17% can discriminate responders from non-
responders with 95% sensitivity and 91% specificity rates.
Feissel et al. [36] reported that in septic patients PVI values
were significantly higher in responders to hydroxylethyl starch
infusion vs. non-responders with significant correlation with
the percent changes induced by intervention in aortic
velocity-time integral measured using transthoracic echocar-
diography and PVI at 19% discriminates responders from
non-responders with sensitivity, specificity and AUC of 94%,
87% and 0.97, respectively. Siswojo et al. [37] reported that
pulse oximeter derived from baseline PVI and stroke volumeindex derived from esophageal Doppler were significantly dif-
ferent between responders and non-responders to fluid inter-
vention and baseline PVI at 10.5% could predict fluid
responsiveness with sensitivity and specificity of 88% and
67%, respectively and AUC of 0.84.
Recently, Yu et al. [38] found PVI-based goal-directed fluid
management can reduce the intraoperative fluid amount espe-
cially the crystalloid and blood lactate levels in patients under
general-epidural anesthesia. Chu et al. [39] through systemic
literature review reported sensitivity and specificity rates of
73% and 82%, respectively for PVI to predict fluid responsive-
ness in mechanically ventilated patients with no heterogeneity
within nor between studies and concluded that PVI has reason-
able ability to predict fluid responsiveness.
On contrary, Bahlmann et al. [40] found pulse oximetric
PVI- and esophageal Doppler-based stroke volume optimiza-
tions agreed poorly and did not affect the amount of fluid
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0
3
6
9
12
15
18
21
24
27
30
33
36
Survivors Non-survivors
L/
P
Figure 5 Mean Lactate/Pyruvate ratio (L/P) determined at time of admission and after fluid infusion in studied patients categorized
according to survival ( significant versus non-survivors).
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Figure 6 Cumulative survival rate of studied patients among
differential strata at admission BLL.
458 A.A. Mohamed, A. Essamadministered, and none of both algorithms showed a good
ability to predict fluid responsiveness and concluded that these
results do not support the fluid responsiveness concept.
These discrepancies concerning predictability of PVI to
fluid responsiveness could be attributed to the fact that the
concept is still recently involved in researches and not exam-
ined in wider scale comparative studies and to the variability
of choice of the comparative cutoff point for PVI
[23,36,37,40] and the choice of counter comparative method
[36,37,40].
Fluid resuscitation significantly reduced blood lactate level
(BLL) and calculated L/P ratio with still significantly higher L/P ratio in non-survivors compared to survivors. Persistently
elevated BLL and high L/P ratios were found to be the most
significant predictors for mortality. The reported decreased
BLL may be attributed to increased lactate clearance as evi-
denced by significantly higher UOP after fluid resuscitation
compared to at admission UOP. Also, UOP showed negative
significant correlation with BLL. Both decreased BLL and
increased UOP supported the findings concerning PVI and
indicated improved tissue perfusion, thus supporting the con-
cept of fluid responsiveness. In line with this attribution, Bursˇa
and Pleva [41] suggested that in traumatic hemorrhagic shock
patients, L/P ratio is useful to identify tissue ischemia and can
estimate the effectiveness of fluid resuscitation and an increase
in L/P ratio is an early warning sign of inadequate tissue oxy-
genation and should lead to more detailed hemodynamic and
laboratory monitoring. Bursˇa et al. [42] also suggested that
L/P ratio could be a useful transfusion trigger. Dezman et al.
[43] found that among patients with elevated BLL that did
not decline to <2 mmol/L in response to resuscitative efforts,
the mortality rate was nearly seven times higher than that
among those with an elevated BLL that normalized and logis-
tic regression analysis showed that failure to clear lactate was
associated with death more than any other feature.
Improved mitochondrial function as evidenced by the
increased blood pyruvate after fluid resuscitation compared
to at admission levels, may explain the reported decreased
BLL and L/P ratio especially in survivors and was found to
be significant specific predictor for survival. In support of this
assumption, Nuzzo et al. [44] found pyruvate dehydrogenase
(PDH) activity and quantity in septic patients were signifi-
cantly lower than in healthy controls and in non-survivor com-
pared to survivors and concluded that PDH activity and
quantity are low in sepsis, and this may cause cells to shift
to anaerobic metabolism, resulting in increased lactate and
decreased pyruvate production.
Interestingly, 11 of non-survivors (91.7%) and 34 of sur-
vivors (73.9%) had at admission BLL >2 mmol/L, while 6
of non-survivors (50%) and only 9 of survivors (19.6%) had
Table 5 Correlation between survival (n= 46) and evaluated parameters.
At ICU admission After fluid resuscitation
SI PVI BLL BPL L/P Hg% UOP SI PVI BLL BPL L/P Hg% UOP
‘‘r” 0.236 0.494 0.344 0.316 0.483 +0.168 +0.157 0.317 +0.529 0.672 +0.363 0.800 +0.254 +0.309
P 0.075 0.0008 0.008 0.016 0.0009 0.207 0.756 0.015 0.0005 0.0003 0.005 0.0002 0.191 0.018
‘‘r”: Pearson’s correlation coefficient; () negative correlation; (+): positive correlation; SI: shock index; PVI: pleth variability index; BLL:
blood lactate level; BPL: blood pyruvate level; L/P: lactate/pyruvate ratio; Hg%: hemoglobin concentration; UOP: urine output.
Table 6 Receiver operating characteristic curve analysis of evaluated parameters as predictors for survival (n= 46).
At ICU admission After fluid resuscitation
SI PVI BLL BPL L/P Hg% UOP SI PVI BLL BPL L/P Hg% UOP
AUC 0.399 0.162 0.298 0.667 0.175 0.440 0.457 0.670 0.091 0.075 0.740 0.024 0.387 0.598
SE 0.095 0.072 0.088 0.096 0.079 0.101 0.100 0.103 0.058 0.035 0.096 0.017 0.092 0.095
P 0.282 0.0009 0.032 0.077 0.001 0.526 0.645 0.039 0.0007 0.0005 0.011 0.0002 0.230 0.300
AUC: area under curve; SE: standard error; SI: shock index; PVI: pleth variability index; BLL: blood lactate level; BPL: blood pyruvate level; L/
P: lactate/pyruvate ratio; Hg%: hemoglobin concentration; UOP: urine output.
Table 7 Regression analysis of SI, PVI and L/P as predictors for survival (n= 46).
Statistical model 1 Statistical model 2 Statistical model 3
b t P b t P b t P
L/P 0.594 6.820 0.0004 0.585 6.281 0.0005 0.800 9.988 0.0002
PVI 0.346 3.972 0.0009 0.343 3.685 0.001
SI 0.202 2.980 0.004
SI: shock index; PVI: pleth variability index; L/P: lactate/pyruvate ratio.
Disturbed fluid responsiveness and lactate/pyruvate ratio 459BLL >4 mmol/L; a finding indicating that for differentiation
between survivors and non-survivors, a cutoff point of
2 mmol/L is non-sense while 4 mmol/L had higher predictivity.
In support of such finding Datta et al. [45] found that the odds
ratios for 30-day death, compared to lactate P4, were 0.125
for lactate <2 and 0.273 for lactate 2–<4. Casserly et al.
[46] documented BLL >4 mmol/L is significantly associated
with in-hospital mortality than BLL of 2–3 and 3–4 mmol/L,
thus supporting the use of the cutoff of >4 mmol/L as a qual-
ifier for future trials in severe sepsis or septic shock.
In support of the rational suggestion to rely on multiple
parameters for early prediction of outcome of shocked ICU
patients, Cevik et al. [47] found that in patients who had ele-
vated BLL and SI, the use of mechanical ventilation and
vasoactive drug was significantly higher with higher hospital-
ization rate and in-hospital mortality (54.1%) than in patients
who had elevation of either parameter alone and concluded
that combination of both parameters is effective in predicting
these outcome measures with higher sensitivities and NPV.
Shackelford et al. [48] reported that automated analysis of
triage vital signs, 15 min of pulse oximetry signals, and labora-
tory values including BLL predicted use of blood transfusion
during trauma resuscitation more accurately than triage vital
signs or pulse oximetry analysis alone.
It could be concluded that after fluid resuscitation and
hemodynamic stability, persistently elevated BLL could pre-dict mortality, while elevating BPL could positively predict
survival of septic shock patients admitted to ICU. Continuous
non-invasive evaluation of fluid responsiveness judged by PVI
and SI could provide sensitive screening for survival outcome
of shocked patients. Wider scale comparative studies are
mandatory for establishment of discriminative PVI and BLL
cutoff points for prediction of survival of shocked patients.
Conflict of interest
The authors declared that there is no conflict of interest.
References
[1] Vadakel H, Rizzolo D. Shock: early recognition and
resuscitation are key. JAAPA 2013;26(6):21–4.
[2] Richards JB, Wilcox SR. Diagnosis and management of shock
in the emergency department. Emerg Med Pract 2014;16
(3):1–22.
[3] Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H,
Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R,
Osborn TM, Nunnally ME, Townsend SR, Reinhart K,
Kleinpell RM, Angus DC, Deutschman CS, Machado FR,
Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R.
Surviving Sepsis Campaign Guidelines Committee including the
Pediatric Subgroup Surviving Sepsis Campaign. International
460 A.A. Mohamed, A. Essamguidelines for management of severe sepsis and septic shock:
2012. Crit. Care Med. 2013;41:580–637.
[4] Spanos A, Jhanji S, Vivian-Smith A, Harris T, Pearse RM. Early
microvascular changes in sepsis and severe sepsis. Shock 2010;33
(4):387–91.
[5] Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL.
Persistent microcirculatory alterations are associated with organ
failure and death in patients with septic shock. Crit. Care Med.
2004;32:1825–31.
[6] Naumann DN, Dretzke J, Hutchings S, Midwinter MJ. Protocol
for a systematic review of the impact of resuscitation fluids on
the microcirculation after haemorrhagic shock in animal models.
Syst Rev 2015;4(1):135.
[7] Dinh VA, Ko HS, Rao R, Bansal RC, Smith DD, Kim TE,
Nguyen HB. Measuring cardiac index with a focused cardiac
ultrasound examination in the ED. Am. J. Emerg. Med.
2012;30:1845–51.
[8] Chen C, Kollef MH. Conservative fluid therapy in septic shock:
an example of targeted therapeutic minimization. Crit. Care
2014;18:481.
[9] Klijn E, van Velzen MH, Lima AP, Bakker J, van Bommel J,
Groeneveld AB. Tissue perfusion and oxygenation to monitor
fluid responsiveness in critically ill, septic patients after initial
resuscitation: a prospective observational study. J. Clin. Monit.
Comput. 2015;29(6):707–12.
[10] KarlssonM, Hara N, Morata S, Sjo¨vall F, Kilbaugh T, Hansson
MJ, Uchino H, Elme´r E. Diverse and Tissue Specific
Mitochondrial Respiratory Response in A Mouse Model of
Sepsis-Induced Multiple Organ Failure. Shock 2015, Epub
ahead of print.
[11] Lee I, Hu¨ttemann M. Energy crisis: the role of oxidative
phosphorylation in acute inflammation and sepsis. Biochim.
Biophys. Acta 2014;1842(9):1579–86.
[12] Lorente L, Martı´n MM, Lo´pez-Gallardo E, Iceta R, Sole´-Viola´n
J, Blanquer J, Labarta L, Dı´az C, Jime´nez A, Lafuente N,
Herna´ndez M, Me´ndez F, Medina N, Ferrer-Agu¨ero JM,
Ferreres J, LLimin˜ana MC, Mora ML, Lubillo S, Sa´nchez-
Palacios M, Montoya J, Ruiz-Pesini E. Platelet cytochrome c
oxidase activity and quantity in septic patients. Crit. Care Med.
2011;39(6):1289–94.
[13] Robinson BH. Lactic acidemia. In: Scriver CR, Beaudet AL, Sly
WS, Valle D, editors. The Metabolic and Molecular Bases
of Inherited Disease. New York: McGraw-Hill; 2001. p.
2275–95.
[14] Debray FG, Mitchell GA, Allard P, Robinson BH, Hanley JA,
Lambert M. Diagnostic accuracy of blood lactate-to-pyruvate
molar ratio in the differential diagnosis of congenital lactic
acidosis. Clin. Chem. 2007;53(5):916–21.
[15] Romijn JA, Chinkes DL, Schwarz JM, Wolfe RR. Lactate-
pyruvate interconversion in blood: implications for in vivo
tracer studies. Am. J. Physiol. 1994;266(3 Pt 1):E334–40.
[16] Huang GS, Hu MH, Hung NK, Tsai CS, Liu TC, Liaw WJ. The
current situation and trends in the clinical treatment of shock.
Hu Li Za Zhi. 2010;57(1):11–6.
[17] Yussof SJ, Zakaria MI, Mohamed FL, Bujang MA,
Lakshmanan S, Asaari A. Value of Shock Index in
Prognosticating The Short Term Outcome of Death for
Patients Presenting With Severe Sepsis and Septic Shock in
The Emergency Department. Med. J. Malaysia 2012;67
(4):406–11.
[18] Copes WS, Champion HR, Sacco WJ. The Injury Severity Score
revisited. J. Trauma 1995;28(1):69–77.
[19] Knaus WA, Draper EA, Wagner DP, Zimmerman JE.
APACHE II: a severity of disease classification system. Crit.
Care Med. 1985;13:818–29.
[20] Teasdale G, Jennett B. Assessment and prognosis of coma after
head injury. Acta Neurochir. 1976;34:45–55.[21] Birkhahn RH, Gaeta TJ, Terry D, Bove JJ, Tloczkowski J.
Shock index in diagnosing early acute hypovolemia. Am. J.
Emerg. Med. 2005;23(3):323–6.
[22] Nguyen BV, Vincent JL, Nowak E, Coat M, Paleiron N, Gouny
P, Ould-Ahmed M, Guillouet M, Arvieux CC, Gueret G. The
accuracy of noninvasive hemoglobin measurement by
multiwavelength pulse oximetry after cardiac surgery. Anesth.
Analg. 2011;113(5):1052–7.
[23] Loupec T, Nanadoumgar H, Frasca D, Petitpas F, Laksiri L,
Baudouin D, Debaene B, Dahyot-Fizelier C, Mimoz O. Pleth
variability index predicts fluid responsiveness in critically ill
patients. Crit. Care Med. 2011;39(2):294–9.
[24] Wasserman K, Beaver WL, Davies JA, Pu JZ, Heber D, Whipp
BJ. Lactate, pyruvate and lactate-to-pyruvate ratio during
exercise and recovery. J. Appl. Physiol. 1985;59(3):935–40.
[25] Chung CK, Wang TJ, Yeung CY, Hsieh WS, Lin DS, Ho SC,
Lin SP. Interference and blood sample preparation for pyruvate
enzymatic assay. Clin. Biochem. 2006;39:74–7.
[26] Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM,
Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R,
Calandra T, Dhainaut J, Gerlach H, Harvey M, Marini JJ,
Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT,
Townsend S, Vender JS, Zimmerman JL, Vincent J. Surviving
Sepsis Campaign: international guidelines for management of
severe sepsis and septic shock: 2008. Crit. Care Med.
2008;36:296–327.
[27] Leone M, Boyadjiev I, Boulos E, Antonini F, Visintini P,
Albane`se J, Martin C. A reappraisal of isoproterenol in goal-
directed therapy of septic shock. Shock 2006;26:353–7.
[28] Fukuoka T, Nishimura M, Imanaka H, Taenaka N, Yoshiya I,
Takezawa J. Effects of norepinephrine on renal function in
septic patients with normal and elevated serum lactate levels.
Crit. Care Med. 1989;17(11):1104–7.
[29] Schaffartzik W, Sanft C, Schaefer JH, Spies C. Different dosages
of dobutamine in septic shock patients: determining oxygen
consumption with a metabolic monitor integrated in a
ventilator. Intensive Care Med. 2000;26(12):1740–6.
[30] Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G,
Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter
K. Stress doses of hydrocortisone reverse hyperdynamic septic
shock: a prospective, randomized, double-blind, single-center
study. Crit. Care Med. 1999;27(4):723–32.
[31] Kraemer HC, Theimann S. How many subjects? Statistical
power analysis in research. Newbury Park, CA: Sage; 1987.
[32] Murphy KR, Myors B. Statistical Power Analysis: A Simple and
General Model for Traditional and Modern Hypothesis Tests.
2nd ed. Lawrence Erlbaum Associates, Inc; 2003.
[33] Berger T, Green J, Horeczko T, Hagar Y, Garg N, Suarez A,
Panacek E, Shapiro N. Shock index and early recognition of
sepsis in the emergency department: pilot study. West J Emerg
Med. 2013;14(2):168–74.
[34] Wira CR, Francis MW, Bhat S, Ehrman R, Conner D, Siegel M.
The shock index as a predictor of vasopressor use in emergency
department patients with severe sepsis. West J Emerg Med.
2014;15(1):60–6.
[35] McCall SJ, Musgrave SD, Potter JF, Hale R, Clark AB, Mamas
MA, Metcalf AK, Day DJ, Warburton EA, Bachmann MO.
Myint PK; Anglia Stroke Clinical Network Evaluation Study
(ASCNES) Group. The shock index predicts acute mortality
outcomes in stroke. Int. J. Cardiol. 2015;182:523–7.
[36] Feissel M, Kalakhy R, Banwarth P, Badie J, Pavon A, Faller JP,
Quenot JP. Plethysmographic variation index predicts fluid
responsiveness in ventilated patients in the early phase of septic
shock in the emergency department: a pilot study. J. Crit. Care
2013;28(5):634–9.
[37] Siswojo AS, Wong DM, Phan TD, Kluger R. Pleth variability
index predicts fluid responsiveness in mechanically ventilated
Disturbed fluid responsiveness and lactate/pyruvate ratio 461adults during general anesthesia for noncardiac surgery. J.
Cardiothorac. Vasc. Anesth. 2014;28(6):1505–9.
[38] Yu Y, Dong J, Xu Z, Shen H, Zheng J. Pleth variability index-
directed fluid management in abdominal surgery under
combined general and epidural anesthesia. J. Clin. Monit.
Comput. 2015;29(1):47–52.
[39] Chu H, Wang Y, Sun Y, Wang G. Accuracy of pleth variability
index to predict fluid responsiveness in mechanically ventilated
patients: a systematic review and meta-analysis. J. Clin. Monit.
Comput. 2015, Epub ahead of print.
[40] Bahlmann H, Hahn RG, Nilsson L. Agreement between Pleth
Variability Index and oesophageal Doppler to predict fluid
responsiveness. Acta Anaesthesiol. Scand. 2015. http://dx.doi.
org/10.1111/aas.12632.
[41] Bursˇa F, Pleva L. Anaerobic metabolism associated with
traumatic hemorrhagic shock monitored by microdialysis of
muscle tissue is dependent on the levels of hemoglobin and
central venous oxygen saturation: a prospective, observational
study. Scand J Trauma Resusc Emerg Med. 2014;22:11.
[42] Bursˇa F, Pleva L, Ma´ca J, Sklienka P, Sˇevcˇı´k P. Tissue ischemia
microdialysis assessments following severe traumatic
haemorrhagic shock: lactate/pyruvate ratio as a new
resuscitation end point? BMC Anesthesiol. 2014;14:118.
[43] Dezman ZD, Comer AC, Smith GS, Narayan M, Scalea TM,
Hirshon JM. Failure to clear elevated lactate predicts 24-hourmortality in trauma patients. J Trauma Acute Care Surg.
2015;79(4):580–5.
[44] Nuzzo E, Berg KM, Andersen LW, Balkema J, Montissol S,
Cocchi MN, Liu X, Donnino MW. Pyruvate Dehydrogenase
Activity is Decreased in the Peripheral Blood Mononuclear Cells
of Patients with Sepsis: A Prospective Observational Trial. Ann
Am Thorac Soc. 2015, Sep 10. [Epub ahead of print].
[45] Datta D, Walker C, Gray AJ, Graham C. Arterial lactate levels
in an emergency department are associated with mortality: a
prospective observational cohort study. Emerg Med J. 2015;32
(9):673–7.
[46] Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR,
Osborn TM, Reinhart K, Selvakumar N, Levy MM. Lactate
measurements in sepsis-induced tissue hypoperfusion: results
from the Surviving Sepsis Campaign database. Crit. Care Med.
2015;43(3):567–73.
[47] Cevik AA, Dolgun H, Oner S, Tokar B, Acar N, Ozakin E,
Kaya F. Elevated lactate level and shock index in nontraumatic
hypotensive patients presenting to the emergency department.
Eur J Emerg Med. 2015;22(1):23–8.
[48] Shackelford S, Yang S, Hu P, Miller C, Anazodo A, Galvagno
S, Wang Y, Hartsky L, Fang R, Mackenzie C. ONPOINT Study
Group. Predicting blood transfusion using automated analysis
of pulse oximetry signals and laboratory values. J Trauma Acute
Care Surg. 2015;79(4 Suppl 2):S175–80.
